Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Radiation Oncology Market 2018-2024 -

Research and Markets
Posted on: 08 Mar 18

The "Global Radiation Oncology Market Trends and Drivers, Restraints, and Opportunities 2018-2024" report has been added to's offering.

The Global Radiation Oncology market is estimated to witness a CAGR of 6.7% during the forecast period 2018-2024

The radiation oncology market is booming due to increasing incidences of cancer globally, increasing elderly population, and technological advancements. The high cost of instrument and therapy, side effects, and lack of trained technicians in developing countries are few of the factors hampering the market growth. The markets in emerging countries are expected to grow rapidly during the forecast period due to increasing healthcare spending, growing patient pool, and increasing healthcare awareness among the public.

The market, by therapy type, is segmented into external beam radiation therapy, internal beam radiation therapy, and systemic radiation therapy. External beam radiation therapy occupied the largest share in 2017 due to its high usability, and it is a highly effective treatment for various cancer types such as prostate cancer (that can cure up to 95% of cases). External beam radiation therapy is further segmented by technology and products. The technologies include IGRT, IMRT, VMAT, SBRT, SRS, IMPT, and others. Various products include linear accelerators and proton therapy systems among others.

The market, by application, is segmented into prostate cancer, cervical cancer, breast cancer, lung cancer, head & neck cancer, brain cancer, and others. Prostate cancer occupies the largest market share and is expected to be the fastest growing segment during the forecast period.

The market, by end-users, is segmented into hospitals, radiation therapy centers, ambulatory service centers, and others. Hospitals occupied a significant share of the radiation oncology market in 2016, and this trend is expected to continue for the next 5 years.

Market Dynamics


  • Growing incidence of cancer globally
  • Advancement in technology


  • Growing elderly population
  • Increasing adoption of non-invasive procedures in emerging countries


  • Lack of trained technicians in developing countries
  • Side effects
  • High cost of instrument and therapy

Key Topics Covered:

1. Industry Outlook

2. Report Outline

3. Market Snapshot

4. Market Outlook

5. Market Characteristics

6. Therapy type: Market Size and Analysis

7. Application: Market Size and Analysis

8. End Users: Market Size and Analysis

9. Regions: Market Size and Analysis

10. Competitive Landscape

11. Vendor Profiles

  • Accuray Incorporated
  • Elekta
  • Varian Medical Systems
  • C. R. Bard, Inc.
  • IBA worldwide

12. Companies to Watch For

  • Mevion Medical Systems
  • Nordion, Inc.
  • IsoRay, Inc.
  • Hitachi Medical Corporation
  • ViewRay, Inc.

For more information about this report visit

View source version on

Business Wire

Last updated on: 08/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.